BRCA-mutation carriers with history of early-onset breast cancer may benefit from risk-reducing surgery
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral ...
EurekAlert!4d
BRCA-mutation carriers with a history of early-onset breast cancer may benefit from risk-reducing surgery
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...
Breast, ovary removal might extend lives of women with breast cancer genes
New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...
News Medical3d
Risk-reducing surgeries provide benefits for young BRCA-mutation carriers
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...
Armed robbery in Revesby3d
Surgery May Benefit BRCA Carriers With Early Breast Cancer
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral ...
Cancer therapy shows long-term survival benefits for patients with high-risk, BRCA-positive breast cancer in trial
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to ...
Armed robbery in Revesby3d
PARP Inhibitors Boost Survival in High-Risk BRCA Breast Cancer
Patients with high-risk, BRCA-positive breast cancer who received olaparib after standard treatment continued to have better ...
Cure Today3d
Lynparza Continues to Benefit in BRCA1/2+, HER2- Breast Cancer
Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.
cancerhealth2d
BRCA Mutation Carriers With Early-Onset Breast Cancer May Benefit From Risk-Reducing Surgery
Women who underwent bilateral mastectomy or removal of ovaries and Fallopian tubes had lower rates of recurrence, ovarian ...
News Medical3d
Olaparib provides survival benefits for high-risk BRCA-positive breast cancer patients
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after a median ...